Key Event: Board Meeting
A meeting of the Board of Directors of Piramal Pharma Limited is scheduled to be held on Wednesday, 29th July 2026. The primary agenda for the meeting is to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June 2026 (Q1 FY27).
Trading Window Closure
In relation to the results announcement, the company confirms that the 'Trading Window' for dealing in the company's securities has been closed since Wednesday, 1st July 2026. The window will remain closed until Friday, 31st July 2026 (both days inclusive). The trading window is scheduled to reopen on Saturday, 1st August 2026.